191 related articles for article (PubMed ID: 34418963)
21. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
[TBL] [Abstract][Full Text] [Related]
22. Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.
Decker A; Welzel M; Laubner K; Grundmann S; Kochs G; Panning M; Thimme R; Bode C; Wagner D; Lother A
Am J Transplant; 2020 Nov; 20(11):3239-3245. PubMed ID: 32519406
[TBL] [Abstract][Full Text] [Related]
23. Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review.
Gupta S; Parker J; Smits S; Underwood J; Dolwani S
Colorectal Dis; 2020 Jun; 22(6):611-620. PubMed ID: 32418307
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
[TBL] [Abstract][Full Text] [Related]
25. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay.
Bordi L; Sberna G; Lalle E; Piselli P; Colavita F; Nicastri E; Antinori A; Boumis E; Petrosillo N; Marchioni L; Minnucci G; D'Agostini E; Castilletti C; Locatelli F; Zumla A; Ippolito G; Capobianchi MR; On Behalf Of Inmi ReCOVeRI Study Group
Viruses; 2020 Oct; 12(10):. PubMed ID: 33092065
[TBL] [Abstract][Full Text] [Related]
26. Persistence of SARS-CoV-2 RNA in the nasopharyngeal, blood, urine, and stool samples of patients with COVID-19: a hospital-based longitudinal study.
Joukar F; Yaghubi Kalurazi T; Khoshsorour M; Taramian S; Mahfoozi L; Balou HA; Jafarinezhad A; Pourkazemi A; Hesni E; Asgharnezhad M; Shenagari M; Jahanzad I; Naghipour M; Maroufizadeh S; Mansour-Ghanaei F
Virol J; 2021 Jul; 18(1):134. PubMed ID: 34210325
[TBL] [Abstract][Full Text] [Related]
27. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.
Hu F; Chen F; Ou Z; Fan Q; Tan X; Wang Y; Pan Y; Ke B; Li L; Guan Y; Mo X; Wang J; Wang J; Luo C; Wen X; Li M; Ren P; Ke C; Li J; Lei C; Tang X; Li F
Cell Mol Immunol; 2020 Nov; 17(11):1119-1125. PubMed ID: 33037400
[TBL] [Abstract][Full Text] [Related]
28. Hereditary prostate cancer as a feature of Lynch syndrome.
Bauer CM; Ray AM; Halstead-Nussloch BA; Dekker RG; Raymond VM; Gruber SB; Cooney KA
Fam Cancer; 2011 Mar; 10(1):37-42. PubMed ID: 20872076
[TBL] [Abstract][Full Text] [Related]
29. Prolonged rectal shedding of SARS-CoV-2 in a 22-day-old-neonate: a case report.
Holm-Jacobsen JN; Vonasek JH; Hagstrøm S; Donneborg ML; Sørensen S
BMC Pediatr; 2021 Nov; 21(1):506. PubMed ID: 34772377
[TBL] [Abstract][Full Text] [Related]
30. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
[TBL] [Abstract][Full Text] [Related]
31. Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report.
Arai T; Mukai S; Kazama R; Ogawa Y; Nishida K; Hatanaka K; Gohma I
J Infect Chemother; 2022 Jun; 28(6):810-813. PubMed ID: 35115239
[TBL] [Abstract][Full Text] [Related]
32. The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome.
Martín-López JV; Fishel R
Fam Cancer; 2013 Jun; 12(2):159-68. PubMed ID: 23572416
[TBL] [Abstract][Full Text] [Related]
33. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
34. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
Kravochuck SE; Church JM
ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
[TBL] [Abstract][Full Text] [Related]
35. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
[TBL] [Abstract][Full Text] [Related]
36. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
Stankiewicz Karita HC; Dong TQ; Johnston C; Neuzil KM; Paasche-Orlow MK; Kissinger PJ; Bershteyn A; Thorpe LE; Deming M; Kottkamp A; Laufer M; Landovitz RJ; Luk A; Hoffman R; Roychoudhury P; Magaret CA; Greninger AL; Huang ML; Jerome KR; Wener M; Celum C; Chu HY; Baeten JM; Wald A; Barnabas RV; Brown ER
JAMA Netw Open; 2022 Jan; 5(1):e2142796. PubMed ID: 35006245
[TBL] [Abstract][Full Text] [Related]
37. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
38. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
[TBL] [Abstract][Full Text] [Related]
39. [P323L Mutation in a Case with Prolonged SARS-CoV-2 PCR Positivity].
Yücebağ E; Arslan N; Tok Y; Nohut OK; Salman Yılmaz S; Kuşkucu MA; Midilli K
Mikrobiyol Bul; 2023 Jul; 57(3):490-497. PubMed ID: 37462312
[TBL] [Abstract][Full Text] [Related]
40. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A;
J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
